Preview

Epilepsy and paroxysmal conditions

Advanced search

The evolution of the publishing strategy and its effect on the journal's bibliometric performance

https://doi.org/10.17749/2077-8333/epi.par.con.2026.288

Abstract

The journal “Epilepsy and Paroxysmal Conditions”, published since 2009, demonstrated steady positive dynamics in key scientometric indicators at year-end 2025. In May 2026, based on updated data, the journal moved to the third quartile (Q3) of the authoritative international scientometric database Scopus, thereby confirming its growing international recognition. At the same time, the journal achieved leading positions among peer-reviewed publications in the "Neurosciences" category in the Russian Science Citation Index (RSCI), evidencing its leading role in the national academic space. The key drivers of growth were the open-access model, the introduction of HTML versions of articles, as well as refinement of requirements for the methodological quality of manuscripts. An analysis of publication activity shows increased proportion of original research, a rise in the number of citations in high-ranking journals, as well as prominently expanded readership. The paper also examines new legal requirements for the publication of genetic data, which come into force in Russia in 2026, and outlines strategic prospects to further promote the journal in international scientometric databases. The journal continues to serve as a key communication platform for Russian and foreign researchers in the field of neurosciences, practicing physicians specializing in various areas of neurology, instrumental diagnostic methods, therapy, pediatrics, neonatology, physical and rehabilitation medicine, and related fields.

About the Author

D. V. Blinov
Institute for Preventive and Social Medicine; Federal Scientific and Clinical Center for Medical Rehabilitation and Balneology of the Federal Medical and Biological Agency; Moscow Haass Medical Social Institute
Russian Federation

Dmitry V. Blinov, Dr. Sci. Med., MBA

WoS ResearcherID: E-8906-2017. Scopus Author ID: 6701744871

11-13/1 Lyalin Passage, Moscow 101000

37А bldg 1 Altufyevskoe Shosse, Moscow 127410

5 bldg 1-1a 2nd Brestskaya Str., Moscow 123056



References

1. Colledge L., James C. A “basket of metrics” – the best support for understanding journal merit. Eur Sci Editing. 2015; 41 (3): 61–5.

2. Parkacheva V.L., Shevsky D.S., Polikhina N.A., et al. Peer-reviewed scientific journals in which the main scientific results of dissertations must be published: existing problems and ways to solve them. Science Editor and Publisher. 2025; 10 (1): 137–53 (in Russ.). https://doi.org/10.24069/SEP-25-29.

3. Trapp J.V. The new Scopus CiteScore formula and the Journal Impact Factor: a look at top ranking journals and middle ranking journals in the Scopus categories of General Physics and Astronomy, Materials Science, General Medicine and Social Sciences. Phys Eng Sci Med. 2020; 43 (3): 739–48. https://doi.org/10.1007/s13246-020-00903-1.

4. Rahman Z., Paul P., Rahaman M.S., Ansari K.M.N. Evaluation of health care science and services journals: impact factors and ranking indicators. J Hosp Librarian. 2024; 24 (4): 325–52. https://doi.org/10.1080/15323269.2024.2395767.

5. Kendall G. More transparency is needed when citing h-indexes, journal impact factors and CiteScores. Publ Res Quarterly. 2024; 40 (1): 80–99. https://doi.org/10.1007/s12109-024-09983-3.

6. Shastry A., Lakshmi T. A., Sridevi N.S. Comparative analysis of Impact Factor, Cite Score, and h-Index of anatomy lournals: a bibliometric study. Int J Acad Med Pharm. 2026; 8 (2): 724–7. https://doi.org/10.47009/jamp.2026.8.2.135.

7. Björk B.C., Solomon D. Open access versus subscription journals: a comparison of scientific impact. BMC Med. 2012; 10: 73. https://doi.org/10.1186/1741-7015-10-73.

8. Xie F., Ghozy S., Kallmes D.F., Lehman J.S. Do open-access dermatology articles have higher citation counts than those with subscription-based access? PLoS One. 2022; 17 (12): e0279265. https://doi.org/10.1371/journal.pone.0279265.

9. Yi H., Cao Y., Leng Q., et al. The impact of open access on citations, Pageviews, and downloads: a scientometric analysis in Postgraduate Medical Journal. Postgrad Med J. 2024; 100 (1187): 679–85. https://doi.org/10.1093/postmj/qgae047.

10. Nishikawa K., Murakami A. Does open access foster interdisciplinary citations? Decomposing open access citation advantage. Scientometrics. 2025; 130 (1): 2963–86. https://doi.org/10.1007/s11192-025-05297-z.

11. Arefjev P.G., Eremenko G.O., Glukhov V.A. Russian Science Citation Index – a tool for science analysis. Bibliosphere. 2012; S: 66–71 (in Russ.).

12. Blinov D.V. To the authors: International Contest of Scholarly Articles results and publication activity brief analysis. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (1): 8–18 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.244.

13. Yakimov A.M., Timechko E.E., Paramonova A.I., et al. Hypotheses of development and strategies for overcoming drug resistance in epilepsy. Рart II: Overcoming strategies. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (1): 59–70 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.211.

14. Galankin N.A., Tadtaeva Z.G., Sardaryan I.S., et al. Impact of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms on antiepileptic drug safety and efficacy. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (1): 71–81 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.240.

15. Korabelnikov D.I., Tkachenko Е.V., Magomedaliev M.O. Phantom pain: epidemiology and etiopathogenesis. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (1): 82–93 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.222.

16. Birkun A.A. Schoolteachers’ and pupils’ attitudes towards and misbeliefs about first aid for seizures: a scoping review. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (2): 200–7. https://doi.org/10.17749/2077-8333/epi.par.con.2025.223.

17. Shnayder N.A., Pekarets N.A., Pekarets N.I., et al. The role of microRNAs as regulators of systemic inflammatory response in anticonvulsant-induced metabolic syndrome. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (2): 208–26 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.239.

18. Kanshina D.S., Akhadov T.A., Mel'nikov I.A., et al. Post-traumatic epilepsy in children: developmental predictors and treatment strategy. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (2): 227–33 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.236.

19. Korabelnikov D.I., Tkachenko Е.V. Non-painful phantom limb sensations. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (2): 234–42 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.235.

20. Vasilenko A.V., Novichkova D.A., Ismailov S.G., et al. Epileptic aura in medicine and literature. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (3): 287–96 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.234.

21. Dhall M., Tushir R., Sharma P., et al. Bioelectronic medicine: a new frontier for autonomic nervous system disorders. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (3): 297–307. https://doi.org/10.17749/2077-8333/epi.par.con.2025.231.

22. Korabelnikov D.I., Tkachenko Е.V. Descriptions of the phantom limbs in literature. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (3): 308–14 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.229.

23. Torshin I.Yu., Gromov A.N., Gromova O.A. A need to replenish essential lithium microdoses in epilepsy suggested by clinical and epidemiological studies on lithium as a factor for preventing impulsive behavior, suicide, stress disorders. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (3): 315–25 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.246.

24. Maksimova M.Yu., Teplyshova A.M. Temporal epilepsy: contribution of molecular genetics to epileptogenesis mechanisms. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (4): 402–9 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.265.

25. Zykov V.P., Murachueva F.A., Chebanenko N.V., Alieva R.M. Clinical and anamnestic factors of epilepsy development and course in children with cerebral palsy. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (1): 19–26 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.237.

26. Utyasheva A.A., Ivin N.O., Ishmuratov E.V., et al. Analysis of incomplete remission cases in post-surgery patients with focal drug-resistant epilepsy. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (1): 27–39. https://doi.org/10.17749/2077-8333/epi.par.con.2025.199.

27. Maximova M.Yu., Golovneva E.A., Broutian A.G., et al. Bilateral tonic-clonic seizures and status epilepticus in autoimmune encephalitis. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (1): 40–7 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.215.

28. Arunkarthik K., Thasma Santhanakrishnan A. Cow’s milk in infant diet is a risk factor for hypocalcemic seizures. Epilepsia i paroksizmal'nye 2026 Том 18 № 2 sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (1): 48–53. https://doi.org/10.17749/2077-8333/epi.par.con.2025.198.

29. Monakhova A.V., Belousova E.D., Gorchkhanova Z.K. Epilepsy, epileptiform discharges and features of brain magnetic resonance imaging in merosin-deficient muscular dystrophy. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (2): 142–52 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.213.

30. Paronikyan R.G., Sargsyan R.Sh., Sarkissyan J.S., et al. Comparative efficacy evaluation for various anticonvulsant drugs to restraint epileptiform states in rats. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (2): 153–60 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.214.

31. Nemathaga M., Maputle M.S., Makhado L., Mashau N.S. Experiences of people living with epilepsy regarding treatment and interventions in selected rural communities of Limpopo and Mpumalanga Provinces, South Africa. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (2): 161–9. https://doi.org/10.17749/2077-8333/epi.par.con.2025.216.

32. . Romanov A.S., Sharakhova E.F. Quality of life for patients with epilepsy in Russia. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (3): 260–70 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.225.

33. Voronkova K.V., Samartseva E.A. Falls as a significant challenge in medicine: implementation of Falling Patient project outcomes in clinical practice of healthcare professionals (2019–2025). Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (3): 271–8 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.254.

34. Maslova N.N., Chukhontseva E.S., Borovitsky V.S., Litvinenko Ya.A. Epidemiology of epilepsy among pregnant women in the Smolensk Region. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (3): 279–86 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.232.

35. Ivanov A.A., Blinov D.V., Voronkova K.V., et al. Protocol for developing an Open Base of gRAduated EEG Signals (OBRAS). Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (4): 340–50 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.267.

36. Mikhailova N.F., Krasko A.S., Odintsova G.V., et al. “To feed or not to feed?”: assessing long-term effects of breastfeeding on mental development of children from mothers with epilepsy. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (4): 351–70. https://doi.org/10.17749/2077-8333/epi.par.con.2025.250.

37. Biyakaeva M.A., Gordeyeva E.A., Lukasheva A.D., et al. A relation between stereoelectroencephalography parameters and focal drugresistant epilepsy surgery outcomes. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (4): 371–83 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.253.

38. Kanshina D.S., Vasileva D.V., Mikhnevich E.F., et al. The possibilities of video-electroencephalographic monitoring in diagnostics of chronic post-anoxic myoclonus in children: a pilot study. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (4): 384–91 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.241.

39. Torshin I.Yu., Gromova O.A., Rogozin M.A. Microelement composition of ethylmethylhydroxypyridine succinate preparations as quality indicator to pharmaceutically standardize agents for epilepsy adjuvant therapy. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (4): 392–401 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.243.

40. Bedenko A.S. Migraine manifestations due to correction of secondary hyperhomocysteinaemia. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (1): 54–8. https://doi.org/10.17749/2077-8333/epi.par.con.2025.217.

41. Kozhanova T.V., Zhylina S.S., Meshcheryakova T.I., et al. A novel X-linked immune-mediated actinopathy in a boy with anti-NMDA receptor encephalitis and variant in DOCK11 gene. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (2): 170–81 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.230.

42. Malov A.G., Brokhin L.Yu., Veselkova A.V. Severe KCNT1related developmental and epileptic encephalopathy. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (2): 182–8 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.221.

43. Novikova L.B., Faizullina N.M., Akopyan A.P., Ziultsle K.M. Neurological manifestations of hereditary chromosomal diseases. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (2): 189–99 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.226.

44. Blinov D.V., Petrukhin A.S., Voronkova K.V., et al. The ILAE classification of epileptic seizures: the 2025 update. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (2): 122–41 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.251.

45. Korabelnikov D.I., Tkachenko E.V., Magomedaliev M.O. Phantoms and phantom limbs: history of describing the phenomenon. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2024; 16 (4): 409–16 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2024.219.

46. Ivanov A.A. Overview of current software capabilities for EEG recording and analyzing. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2023; 15 (1): 53–69 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2023.144.

47. Ivanov А.А. Overview of mathematical EEG analysis. Quantitative EEG. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2023; 15 (2): 171–92 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2023.154.

48. Ivanov А.А. Description of technical characteristics for EEG equipment and their comparison for electroencephalographs available in Russia. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2023; 15 (4): 384–92 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2023.170.

49. Novikova E.Yu., Ivanov A.A. 2023 IFCN & ILAE minimum recording standards for routine and sleep EEG. Applicability assessment in Russia. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2024; 16 (3): 281–90 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2024.189.

50. Ivanov A.A. Methods for calculating EEG-based epileptiform activity index. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2024; 16 (4): 402–8 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2024.203.

51. Ivanov A.A. Current software opportunities for generating routine EEG reports. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (1): 101–13 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.204.

52. Ivanov A.A. ABCD microstates: a new word in EEG mathematical analysis. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (2): 243–50 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.212.

53. Ivanov A.A. What mysteries does the reference electrode hide? Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (3): 326–31 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.248.

54. Ivanov А.А. High-density EEG. Overview and scope of application. Epilepsia i paroksizmal'nye sostoania / Epilepsy and Paroxysmal Conditions. 2025; 17 (4): 415–23 (in Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2025.247.

55. Resolution of the Government of the Russian Federation of June 15, 2026 No. 750 “On the transfer of human genetic data outside the territory of the Russian Federation”. Available at: http://publication.pravo.gov.ru/document/0001202606190021 (in Russ.) (accessed 19.06.2026).


Review

For citations:


Blinov D.V. The evolution of the publishing strategy and its effect on the journal's bibliometric performance. Epilepsy and paroxysmal conditions. 2026;18(2):100–111. (In Russ.) https://doi.org/10.17749/2077-8333/epi.par.con.2026.288

Views: 11

JATS XML

ISSN 2077-8333 (Print)
ISSN 2311-4088 (Online)